by Elizabeth Kissling | Jun 23, 2010 | Menopause, New Research, Pharmaceutical
The Endocrine Society has released a new, peer-reviewed statement on the risks and benefits of hormone therapy for menopausal women. The upshot is that risks and benefits vary depending on the age of the patient and the length of time since menopause: One interesting...
by Chris Hitchcock | Apr 23, 2010 | Anatomy, Menstruation, New Research
When I was pregnant and then learning to breast-feed my daughter, my doula told me that breast milk had great anti-biotic properties, and that it was good to use on eye-infections and cuts. Turns out that there is science behind that. Not only that, but now scientists...
by Elizabeth Kissling | Apr 18, 2010 | Menopause, New Research, Newspapers, Pharmaceutical
Guest Post by Paula S. Derry, Ph.D. Déjà vu An article in today’s New York Times Magazine recounts the author’s experience with a debilitating depression that began during her perimenopause, the transitional time leading up to menopause. For her, prescription...
by Elizabeth Kissling | Feb 7, 2010 | Menopause, New Research, Pharmaceutical
A study to be published in the British Medical Journal’s Thorax,* which focuses on respiratory medicine, finds that estrogen-only hormone treatment for menopause symptoms is associated with higher risk of asthma. The study involved nearly 58,000 women over 12...
by Elizabeth Kissling | Jan 5, 2010 | Menopause, New Research, Pharmaceutical
As we have often noted here, one of the key reasons the marketing of hormone therapy for menopausal women has been so successful is the misguided belief that menopause is an estrogen-deficiency disease. Among other purported disadvantages of the decline in estrogen...